BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29850505)

  • 1. High Mobility Group Box Protein 1 Serves as a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-
    Wu X; Wang W; Chen Y; Liu X; Wang J; Qin X; Yuan D; Yu T; Chen G; Mi Y; Mou J; Cui J; Hu A; E Y; Pei D
    Biomed Res Int; 2018; 2018():3453706. PubMed ID: 29850505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
    Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
    Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
    Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
    Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
    Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W
    Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
    Pang X; Zhang Y; Zhang S
    Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer.
    Yang CJ; Liu YP; Dai HY; Shiue YL; Tsai CJ; Huang MS; Yeh YT
    Oncotarget; 2015 Oct; 6(30):30263-76. PubMed ID: 26388610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J; Kou YB; Zhu JS; Chen WX; Li S
    Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of high mobility group protein B1 correlates with the proliferation and metastasis of lung adenocarcinoma cells.
    Sun KK; Ji C; Li X; Zhang L; Deng J; Zhong N; Wu XY
    Mol Med Rep; 2013 May; 7(5):1678-82. PubMed ID: 23467607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of integrin-linked kinase promotes lung cancer cell migration and invasion via NF-κB-mediated upregulation of matrix metalloproteinase-9.
    Zhao M; Gao Y; Wang L; Liu S; Han B; Ma L; Ling Y; Mao S; Wang X
    Int J Med Sci; 2013; 10(8):995-1002. PubMed ID: 23801886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of high-mobility group protein box 1 in lung cancer.
    Wu XJ; Chen YY; Gong CC; Pei DS
    J Cell Biochem; 2018 Aug; 119(8):6354-6365. PubMed ID: 29665052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression.
    Zeng Q; Li S; Zhou Y; Ou W; Cai X; Zhang L; Huang W; Huang L; Wang Q
    Cytokine; 2014 Jan; 65(1):24-32. PubMed ID: 24140068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effect of silencing of HMGB1 gene expression on the invasive and metastatic abilities of MGC-803 gastric cancer cells].
    Li ZJ; Song B; Liu J; Han JJ; Wang CX; Zhu YX; Xu ZF
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):244-8. PubMed ID: 23985250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HMGB1-TLR4 in Placentas from Preeclamptic Pregnancies and Its Effect on Proliferation and Invasion of HTR-8/SVneo Cells.
    He L; Song Q; Hu J; Wu J
    Gynecol Obstet Invest; 2023; 88(3):159-167. PubMed ID: 36882022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70.
    Gong W; Wang ZY; Chen GX; Liu YQ; Gu XY; Liu WW
    Oncol Rep; 2013 Sep; 30(3):1249-56. PubMed ID: 23836405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway.
    Cai J; Li R; Xu X; Zhang L; Wu S; Yang T; Fang L; Wu J; Zhu X; Li M; Huang Y
    Oncotarget; 2015 Nov; 6(34):36489-504. PubMed ID: 26429875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of HMGB1 protects against the development of acute lung injury after severe acute pancreatitis.
    Luan ZG; Zhang XJ; Yin XH; Ma XC; Zhang H; Zhang C; Guo RX
    Immunobiology; 2013 Oct; 218(10):1261-70. PubMed ID: 23706497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
    Chen Y; Lin C; Liu Y; Jiang Y
    Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A; Tu Z; Yin B
    Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.